STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the first quarter ended April 1, 2022. First Quarter 2022 Overview Record Net Sales of $63.2 Million Up 25% from the Prior Year Quarter ICL Sales of $58.7 Million Up 26% from the Prior Year Quarter Record ICL Units Up 29% from the Prior Year Quarter Gross Margin at 77.9%